Tejnaksh Healthcare Ltd.
| BSE: 539428 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE030T01019 |
| BSE 00:00 | 05 Mar | 69.55 |
2.15 (3.19%) |
OPEN
70.50 |
HIGH
70.95 |
LOW
66.05 |
| NSE 05:30 | 01 Jan | Tejnaksh Healthcare Ltd |
| OPEN | 70.50 |
| PREVIOUS CLOSE | 67.40 |
| VOLUME | 24205 |
| 52-Week high | 77.20 |
| 52-Week low | 22.95 |
| P/E | 53.09 |
| Mkt Cap.(Rs cr) | 71 |
| Buy Price | 66.05 |
| Buy Qty | 100.00 |
| Sell Price | 70.00 |
| Sell Qty | 636.00 |
Tejnaksh Healthcare Ltd. (TEJNAKSHHEALTH) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 862.60 | -11.90 | -1.36 | 13266.48 |
| Cipla | 805.45 | -0.75 | -0.09 | 12659.15 |
| Sun Pharma.Inds. | 610.95 | -7.70 | -1.24 | 12531.93 |
| Dr Reddy's Labs | 4489.40 | -84.90 | -1.86 | 11850.40 |
| Lupin | 1031.95 | -16.20 | -1.55 | 11025.66 |
| Apollo Hospitals | 2881.75 | -161.70 | -5.31 | 9794.50 |
| Glenmark Pharma. | 467.90 | -6.10 | -1.29 | 6712.63 |
| Alkem Lab | 2780.80 | -46.40 | -1.64 | 6677.08 |
| Cadila Health. | 442.20 | -6.80 | -1.51 | 6347.40 |
| Torrent Pharma. | 2483.40 | -14.40 | -0.58 | 6168.44 |
| Divi's Lab. | 3495.85 | -58.45 | -1.64 | 5310.57 |
| Ipca Labs. | 1925.05 | -6.10 | -0.32 | 4337.82 |
| Piramal Enterp. | 1924.30 | -32.60 | -1.67 | 4219.19 |
| Alembic Pharma | 916.85 | -5.15 | -0.56 | 4132.55 |
| Abbott India | 14758.90 | 112.90 | 0.77 | 4093.14 |
| Glaxosmi. Pharma | 1545.30 | 3.65 | 0.24 | 3224.68 |
| Jubilant Pharmo | 759.40 | -24.30 | -3.10 | 3139.90 |
| Sanofi India | 8237.85 | -89.05 | -1.07 | 3070.60 |
| Laurus Labs | 351.30 | -17.05 | -4.63 | 2797.34 |
| Gland Pharma | 2550.90 | -120.20 | -4.50 | 2633.24 |
Quick Links for Tejnaksh Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
